小鼠中LIGHT(TNFSF14)细胞因子基因失活可恢复葡萄糖稳态并减轻肝脂肪变性
该研究在高脂高胆固醇饮食(HFHCD)喂养的小鼠中探索促炎细胞因子LIGHT(TNFSF14)在非酒精性脂肪性肝病(NAFLD)和2型糖尿病中的作用。结果显示,LIGHT缺陷可改善HFHCD喂养小鼠的葡萄糖耐量和胰岛素敏感性,降低肝脏炎症和NAFLD活动评分,并减少全身及脂肪组织炎症。提示阻断LIGHT信号可能有助于恢复肝脏稳态并抑制NAFLD。
要点
- LIGHT缺陷改善HFHCD喂养小鼠的葡萄糖耐量和胰岛素敏感性。
- LIGHT缺陷降低HFHCD小鼠肝脏炎症和NAFLD活动评分。
- 阻断LIGHT信号可能成为NAFLD治疗策略。
核心结论
- LIGHT缺陷在HFHCD喂养小鼠中改善肝脏葡萄糖耐量并减少肝脏炎症和NAFLD。
- 这些改变伴随全身炎症和脂肪组织细胞因子分泌减少以及Klf6和Tlr4等关键基因表达变化。
- 阻断LIGHT依赖信号可能有助于恢复肝脏稳态并抑制NAFLD。
研究设计与样本
- 研究使用LIGHT缺陷(Light-/-)小鼠和野生型(WT)对照,分别喂养常规饲料(RCD)或高脂高胆固醇饮食(HFHCD)16周。
- 在RCD和HFHCD喂养的Light-/-与WT小鼠中评估葡萄糖耐量、胰岛素敏感性、NAFL、全身及组织炎症和代谢基因表达。
- 还在HFHCD喂养的Irs2+/-小鼠(胰岛素信号受损)中评估LIGHT缺陷对肝组织和炎症的影响。
主要发现
- LIGHT缺陷对RCD喂养WT小鼠的代谢、NAFL或组织及全身炎症无影响。
- HFHCD喂养WT小鼠肝脏中HVEM和LTβR较RCD喂养WT对照显著增加。
- HFHCD喂养下,LIGHT缺陷改善葡萄糖耐量和胰岛素敏感性。
- HFHCD喂养的Light-/-小鼠较WT对照NAFLD活动评分(NAS)、肝脏CD3+ T淋巴细胞和F4/80+巨噬细胞减少。
- Light-/-小鼠脂肪组织中抗炎F4/80+CD206+巨噬细胞增多、促炎F4/80+CD11c+巨噬细胞减少,脂肪组织外植体分泌MCP1、TNF-α和IL-17减少。
临床怎么用
- 研究提示LIGHT(TNFSF14)信号通路可能是NAFLD和2型糖尿病相关代谢炎症的潜在干预靶点。
- 未来可考虑开发阻断LIGHT依赖信号的疗法以恢复肝脏稳态并抑制NAFLD进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Non-alcoholic fatty liver disease (NAFLD) is frequently associated with type 2 diabetes mellitus. Progression of NAFLD is mediated, among other things, by activation of inflammatory pathways. In the present study, the role of the proinflammatory cytokine LIGHT (TNFSF14) was explored in NAFLD and type 2 diabetes mellitus in mice deficient for the cytokine. METHODS: Light-deficient (Light-/-) mice and WT controls were fed a regular chow diet (RCD) or a high-fat high-cholesterol diet (HFHCD) for 16 weeks. The expression of LIGHT and its receptors, herpes virus entry mediator (HVEM) and lymphotoxin β receptor (LTβR), was investigated in both dietary regimens. Glucose tolerance, insulin sensitivity, non-alcoholic fatty liver (NAFL), systemic and tissue inflammation, and metabolic gene expression were explored in Light-/- and WT mice fed an RCD and an HFHCD. The effect of Light deficiency was also evaluated in hepatic tissue and in inflammation in HFHCD-fed Irs2+/- mice with impaired insulin signalling. RESULTS: Light deficiency did not have an effect on metabolism, in NAFL or in tissue and systemic inflammation, in RCD-fed WT mice. HVEM and LTβR were markedly increased in livers of HFHCD-fed WT mice compared with RCD-fed WT controls. In WT mice under HFHCD, Light deficiency improved glucose tolerance and insulin sensitivity. Non-alcoholic fatty liver disease activity (NAS) score, hepatic CD3+ T lymphocytes and F4/80+ macrophages were decreased in HFHCD-fed Light-/- mice compared with HFHCD-fed WT controls. Consistent with a potential role of adipose tissue in hepatic homeostasis, Light-/- mice exhibited augmented anti-inflammatory F4/80+CD206+ adipose tissue macrophages and reduced proinflammatory F4/80+CD11c+ adipose tissue macrophages. Moreover, adipose tissue explants from Light-/- mice showed diminished secretion of monocyte chemoattractant protein 1 (MCP1), TNF-α and IL-17 cytokines. Circulating Light-/- leucocytes consistently displayed augmented levels of the patrolling Ly6Clow monocytes, decreased Th9 T cell subset and diminished plasma TNF-α and IL-6 levels. Similarly, Light deficiency in Irs2+/- mice, which display impaired insulin signalling, also reduced NAFL as well as systemic and adipose tissue inflammation. Analysis of hepatic gene expression in Light-/- mouse livers showed reduced levels of Zbtb16, the transcription factor essential for natural killer T (NKT) cell function, and two genes related to NAFLD and fibrosis, Klf6 and Tlr4. CONCLUSIONS/INTERPRETATION: These results indicate that Light deficiency in HFHCD improves hepatic glucose tolerance, and reduces hepatic inflammation and NAFL. This is accompanied by decreased systemic inflammation and adipose tissue cytokine secretion and by changes in the expression of key genes such as Klf6 and Tlr4 involved in NAFLD. These results suggest that therapies to block LIGHT-dependent signalling might be useful to restore hepatic homeostasis and to restrain NAFLD.
引用
- Herrero-Cervera A, Vinué Á, Burks DJ, et al. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis. Diabetologia. 2019. PMID: 31388695. doi:10.1007/s00125-019-4962-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。